To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.

Marieke J H BegemannIlse A ThompsonWim VelingShiral S GangadinChris N W GeraetsErna van 't HagSanne J Müller-KuperusPriscilla P OomenAlban E VoppelMark van der GaagMartijn J KikkertJim Van OsH Filip E SmitRikus H KnegteringSybren WiersmaLuyken H StoutenHarm J GijsmanLex WunderinkAnton B P StaringSelene R T VeermanAmrita G S MahabirJörg KurkampGerdina H M PijnenborgNatalie D VeenMachteld MarcelisKoen P GrootensGunnar FaberNico J van BeverenAgaath BeenTruus van den BrinkMaarten BakTherese A M J van AmelsvoortAndrea RuissenChristine BlankeKarin GroenLieuwe de HaanIris E C Sommer

Published in: Trials (2020)

European Clinical Trials Database, EudraCT number 2017-002406-12. Registered 7 June 2017.

Keyphrases

study protocol
clinical trial
randomized controlled trial
adverse drug
double blind
healthcare
phase ii
open label
cross sectional
emergency department
systematic review
placebo controlled
electronic health record